Disclosure under Regulation 30 of SEBI(LODR)Regulations ,2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Narmada Macplast Drip Irrigation Systems Ltd has informed the stock exchange that it is in talks with the management of GSK Industries Private Limited to acquire a 51% stake in the company. The purpose of the proposed investment is stated as horizontal integration of business, meaning the company wants to expand within the same industry line. The acquisition is currently at the discussion stage and no definitive agreement has been announced yet. The company has committed to make further timely disclosures as the proposal progresses. Narmada Macplast is a listed entity on BSE (Scrip Code: 517431) based in Gujarat.
If completed, the 51% acquisition would give Narmada Macplast majority control of GSK Industries and enable horizontal expansion, which could positively impact revenue and market reach in the drip irrigation segment. However, since the deal is still in talks with no confirmed terms, there is no immediate impact on the stock price — investors should wait for further disclosures on deal value and timelines.